GAVINIUM, oral suspension in a sachet 12 sachets of 10 ml
Active ingredients: Sodium alginate, Sodium bicarbonate, Calcium carbonate
Commercialized according to BDPM
Oral suspension12 sachets of 10 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GAVINIUM, suspension buvable en sachet
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 12 sachet(s) polyester aluminium polyéthylène de 10 ml
- Marketing authorisation holder
- RECKITT BENCKISER HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 9 Mar 2026
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69026912CIP73031909CIP133400930319093Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CARBONATE DE CALCIUMsuspension | 325 mg · un sachet de 10 mL | SA |
| BICARBONATE DE SODIUMsuspension | 213 mg · un sachet de 10 mL | SA |
| ALGINATE DE SODIUMsuspension | 500 mg · un sachet de 10 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.